Cavanaugh P F, Moskwa P S, Donish W H, Pera P J, Richardson D, Andrese A P
Chemotherapeutics Research Laboratory, Eastman Kodak Company, Rochester, New York 14650.
Invest New Drugs. 1990 Nov;8(4):347-54. doi: 10.1007/BF00198590.
A semi-automated colorimetric chemosensitivity assay was developed. The assay utilizes the vital stain neutral red for the rapid screening of potential anticancer agents using solid tumor cell lines. The cell lines used in this assay and presented in this report are CX-1 colon adenocarcinoma and A549 lung carcinoma. The assay, performed in 96 well tissue culture plates, allows for short drug exposure times (3 hrs.) followed by quantitation of cell number (neutral red absorbance) following four cell doubling times. Cell number directly correlated with absorbance of eluted neutral red at 540 nm. However, optimal amounts of dye and staining times varied between cell lines. IC50 concentrations (for inhibition of cell growth) determined using this assay were in good agreement with results from clonogenic assays using similar drug treatment conditions. The assay technique was determined to be capable of detecting antineoplastic compounds operating by a wide variety of mechanisms.
开发了一种半自动比色化学敏感性测定法。该测定法利用活性染料中性红,通过实体瘤细胞系快速筛选潜在的抗癌药物。本测定法中使用并在本报告中呈现的细胞系为CX - 1结肠腺癌和A549肺癌。该测定法在96孔组织培养板中进行,允许短时间药物暴露(3小时),然后在四个细胞倍增时间后对细胞数量进行定量(中性红吸光度)。细胞数量与在540nm处洗脱的中性红吸光度直接相关。然而,染料的最佳用量和染色时间在不同细胞系之间有所不同。使用该测定法确定的IC50浓度(用于抑制细胞生长)与在类似药物处理条件下的克隆形成测定结果高度一致。该测定技术被确定能够检测通过多种机制起作用的抗肿瘤化合物。